12:58 PM EDT, 08/12/2024 (MT Newswires) -- Atossa Therapeutics ( ATOS ) shares gained 5.6% in recent trading on Monday after the company reported of a narrower Q2 loss.

Atossa reported a Q2 net loss of $0.05 per diluted share, compared with a loss of $0.08 a year earlier.

Analysts polled by Capital IQ expected a loss of $0.06.

Cash and cash equivalents totaled $79.5 million as of June 30, down from $88.5 million as of Dec. 31, the company said.

Price: 1.24, Change: +0.07, Percent Change: +5.56